A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients.

PURPOSE: Poor prognosis of patients with muscle-invasive bladder cancer (BC) that often metastasizes drives the need for discovery of molecular determinants of BC progression. Chondroitin sulfate proteoglycans, including CD44, regulate cancer progression; however, the identity of a chondroitinase (C...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Cancer Res
Главные авторы: Lokeshwar, Vinata B., Morera, Daley S., Hasanali, Sarrah L., Yates, Travis J., Hupe, Marie C., Knapp, Judith S., Lokeshwar, Soum D., Wang, Jiaojiao, Hennig, Martin, Baskar, Rohitha, Escudero, Diogo O., Racine, Ronny R., Dhir, Neetika, Jordan, Andre R., Hoye, Kelly, Azih, Ijeoma, Manoharan, Murugesan, Klaassen, Zachary, Kavuri, Sravankumar, Lopez, Luis E., Ghosh, Santu, Lokeshwar, Bal L.
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7334064/
https://ncbi.nlm.nih.gov/pubmed/32094233
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-2912
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы